Quercetin in Coronary Artery By-pass Surgery

NCT04907253 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Quercetin
DRUG: Placebo

Sponsor

Montreal Heart Institute